Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
13,237,236
-
Share change
-
-6,354,114
-
Total reported value
-
$4,627,350
-
Price per share
-
$0.35
-
Number of holders
-
16
-
Value change
-
-$2,353,825
-
Number of buys
-
4
-
Number of sells
-
8
Institutional Holders of BELLEROPHON THERAPEUTICS INC - COM (BLPH) as of Q4 2019
As of 31 Dec 2019,
BELLEROPHON THERAPEUTICS INC - COM (BLPH) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,237,236 shares.
The largest 10 holders included
Puissance Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, VHCP Management II, LLC, VHCP Management III, LLC, Telemetry Investments, L.L.C., GEODE CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, LPL Financial LLC, and Virtu Financial LLC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.